Private Advisor Group’s aTyr Pharma ATYR Stock Holding History

Private Advisor Group’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,736	Closed	-$8K	–	3486
2020 Q2	$8K	Buy	+1,736	New	+$6.3K	﹤0.01%	3047

Other funds holding ATYR

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Private Advisor Group's ATYR Position: Q3 2020 in Review

Private Advisor Group sold out of aTyr Pharma (ATYR) in Q3 2020, closing a stake of 1,736 shares — an estimated $8K sold.

Private Advisor Group first reported a position in ATYR in Q2 2020 and held it in 1 quarter. The position peaked at $8K in Q2 2020. 25 funds tracked by Wall St. Rank hold ATYR as of Q3 2020.

Private Advisor Group reported no remaining aTyr Pharma position as of Q3 2020 after selling out during the quarter.
Private Advisor Group sold 1,736 aTyr Pharma shares in Q3 2020, an estimated $8K.
Private Advisor Group first reported a position in aTyr Pharma in Q2 2020 and held it in 1 quarter.
Private Advisor Group's aTyr Pharma position peaked at $8K in Q2 2020.
25 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.